Brenda Kyle

CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity.

M. Alcorn, Tessa L. Holyoake, Linda Richmond et al. · Journal of Clinical Oncology · 1996 · 108 citations

Medicine, Cell Biology, Hematology +17

Phase Ib trial of bryostatin 1 in patients with refractory malignancies.

Steven Grant, Jane D. Roberts, Elizabeth Poplin et al. · PubMed · 1998 · 51 citations

Medicine, Oncology, Pharmacology +17

Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

John D. Roberts, Elizabeth Poplin, Mary Beth Tombes et al. · Cancer Chemotherapy and Pharmacology · 2000 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +11

Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks

John D. Roberts, Stephen Shibata, Darcy Spicer et al. · Cancer Chemotherapy and Pharmacology · 2000 · 15 citations

Pharmacy, Pharmacology, Pharmacotherapy +4

Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial

Harry D. Bear, John D. Roberts, David L. Cornell et al. · Cancer Immunology Immunotherapy · 2001 · 14 citations · Full text

Life Sciences, Immunology, Oncology +11